Parameters of LRP5 from a structural and molecular perspective
- PMID: 16390319
- DOI: 10.1615/critreveukargeneexpr.v15.i3.50
Parameters of LRP5 from a structural and molecular perspective
Abstract
LRP5, along with LRP6 and their Drosophila homolog, Arrow, constitute a novel subclass of the LDL receptor superfamily. The arrangement of structural motifs in these receptors is different from the other members of the superfamily, and only recently have we begun to understand the functional importance of human LRP5 (and LRP6). Whole genome positional cloning studies have identified a number of mutations in LRP5 that underlie inherited human diseases/phenotypes, particularly those involving the skeleton and the eye. A number of studies have illustrated the importance of Lrp5/6/Arrow as a co-receptor with Frizzled for the Wnt proteins and their critical role in the regulation of the Wnt/beta-catenin signaling pathway. The cataloging of these human mutations, in combination with engineered mutations in mice and other studies involving gene/protein modifications, has led to a better understanding of the function of the various domains in LRP5/6. In this review, we discuss a number of studies that have revealed a wide variety of protein-protein interactions that occur with the various structural motifs in the Lrp5 protein. Ultimately, these interactions regulate the activity of the Wnt/beta-catenin signaling pathway and the role it plays in processes such as bone mass accrual and vision.
Similar articles
-
LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way.Development. 2004 Apr;131(8):1663-77. doi: 10.1242/dev.01117. Development. 2004. PMID: 15084453 Review.
-
A cell-based Dkk1 binding assay reveals roles for extracellular domains of LRP5 in Dkk1 interaction and highlights differences between wild-type and the high bone mass mutant LRP5(G171V).J Cell Biochem. 2009 Dec 1;108(5):1066-75. doi: 10.1002/jcb.22335. J Cell Biochem. 2009. PMID: 19746449
-
LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.Joint Bone Spine. 2005 May;72(3):207-14. doi: 10.1016/j.jbspin.2004.10.008. Joint Bone Spine. 2005. PMID: 15850991 Review.
-
Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize beta-catenin independently of Frizzled proteins.Oncogene. 2004 Jun 17;23(28):4873-84. doi: 10.1038/sj.onc.1207642. Oncogene. 2004. PMID: 15064719 Free PMC article.
-
The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo.Mol Biol Cell. 2009 Feb;20(3):924-36. doi: 10.1091/mbc.e08-07-0711. Epub 2008 Dec 3. Mol Biol Cell. 2009. PMID: 19056682 Free PMC article.
Cited by
-
The role of Lrp5/6 in cardiac valve disease: LDL-density-pressure theory.J Cell Biochem. 2011 Sep;112(9):2222-9. doi: 10.1002/jcb.23182. J Cell Biochem. 2011. PMID: 21590710 Free PMC article. Review.
-
LRP5 sequence and polymorphisms in the baboon.J Med Primatol. 2009 Apr;38(2):97-106. doi: 10.1111/j.1600-0684.2008.00317.x. J Med Primatol. 2009. PMID: 19367734 Free PMC article.
-
N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling.PLoS One. 2009 Dec 14;4(12):e8284. doi: 10.1371/journal.pone.0008284. PLoS One. 2009. PMID: 20011526 Free PMC article.
-
WNT signaling in bone development and homeostasis.Wiley Interdiscip Rev Dev Biol. 2014 Nov-Dec;3(6):489-500. doi: 10.1002/wdev.159. Epub 2014 Sep 30. Wiley Interdiscip Rev Dev Biol. 2014. PMID: 25270716 Free PMC article. Review.
-
Diseases of Wnt signaling.Rev Endocr Metab Disord. 2006 Jun;7(1-2):41-9. doi: 10.1007/s11154-006-9003-3. Rev Endocr Metab Disord. 2006. PMID: 16944325 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases